Legit China steroïde leverancier

Medicijn tegen kanker

» Farma-materialen » Medicijn tegen kanker

AZD-9291 | Osimertinib | Mereletinib CAS 1421373-65-0 AZD9291 lung cancer Treatment

onderzoek
  • Specificaties

AZD-9291 | Osimertinib | Mereletinib CAS 1421373-65-0 AZD9291 lung cancer Treatment Active Pharma Ingredient Sales Contacts. Anticancer drug research chemical use only for sale. AZD-9291 Purity 99% available

AZD-9291 Osimertinib Mereletinib CAS 1421373-65-0 AZD9291 lung cancer Treatment

AZD-9291 | Osimertinib | Mereletinib CAS 1421373-65-0

AZD-9291
Other Names: N(2{[2(diMethylaMino)ethyl](Methyl)aMino}4Methoxy5{[4(1Methyl1Hindol3yl)pyriMidin2yl]aMino}fenyl)prop2enaMide;N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]fenyl]-2-propenamide;AZD9291,AZD-9291
CAS: 1421373-65-0
MF: C28H33N7O2
Mw: 499.61 .

AZD 9291 is an irreversible inhibitor of epidermal growth factor receptor (EGFR) sensitizing and T790M resistance mutations (IC50s = 15-17 nM) while sparing the wild-type form of the receptor (IC50 = 480 nM). It binds the related IGF1R and hERG receptors with significantly reduced potency (IC50s = 2.9 en 16.2 μM, respectively). AZD 9291 has been shown to inhibit tumor growth in a xenograft mouse model at oral doses of 5-10 mg/kg and has been tested clinically in patients with advanced EGFR mutant non-small-cell lung cancer.

CATEGORIE EN TAGS:
Medicijn tegen kanker, Onderzoek chemisch , , , , , , , , , , , , , ,

Aanvraagformulier ( we nemen zo snel mogelijk contact met u op )

Naam:
*
E-mail:
*
Bericht:

Verificatie:
1 + 5 = ?

Misschien vind je het ook leuk